Dr. Geoffrey M. Curtin is a regulatory scientist within the Life Sciences and Pharmaceuticals sector. Geoff is focused on developing behavioral research tools and conducting studies to support regulatory submissions. His work focuses on the individual risks associated with the use of tobacco products, and the population health impact associated with the use of those products. At Womble, he guides clients in survey research and population modeling, as well as reviews and summarizes emerging literature from Public Health and Tobacco Control researchers.
  
Throughout his career, Geoff has leveraged his training and experience – initially in the areas of molecular biology and toxicology, and more recently in the areas of behavioral research and population modeling – to support clients in meeting compliance requirements. While Geoff's skill set is broad, his primary interests are in regulatory science development and engagement. Prior to his current role as a Regulatory Scientist, he held leadership positions at R.J. Reynolds Tobacco Company, where he contributed to product stewardship testing, regulatory toxicology, in vivo toxicology research, and behavioral research. He helped create the Behavioral Research Group at Reynolds and led that group for more than a decade.

Geoff is a Ph.D. graduate in Cell Biology and Toxicology from Texas A&M University and has extensive postgraduate training as an RJR-Leon Golberg Memorial Postdoctoral Fellow at Duke University Medical Center. Geoff has held academic appointments at The University of Texas M.D. Anderson Cancer Center at Science Park and The University of Texas Health Sciences Center at Austin.
 

Representative Experience

  • Directed behavioral research and engagement for all Reynolds American Inc. Tobacco operating companies
  • Developed and conducted behavioral research studies related to regulatory compliance and tobacco product submissions
  • Conducted preclinical inhalation models for chronic disease and product stewardship testing
  • Served as an Assistant Professor of Carcinogenesis, focusing on molecular biology and toxicology